NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV

Overview Fund Activity
Delisted

NBRV was delisted on the 31st of July, 2023.

Back to rankings

41 hedge funds and large institutions have $71.1M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 12 closing their positions.

Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
13
Reduced
10
Closed
12
Calls
$453K
Puts
$9K
Net Calls
+$444K
Net Calls Change
+$461K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$7.96M
2
FI
2
Fosun International
China
$1.59M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.09M
4
FM
4
Frazier Management
Washington
$10.4M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$455K

Top Sellers

1
VC
1
Vivo Capital
California
$10.7M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$0
3
USAA
3
United Services Automobile Association
Texas
$0
4
OAM
4
Oxford Asset Management
United Kingdom
$0
5
CHAM
5
Clear Harbor Asset Management
Connecticut
$87K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
– – -4,694 Closed
TRCT
52
Tower Research Capital (TRC)
New York
– – -3,959 Closed
Barclays
53
Barclays
United Kingdom
$0 26 -100 -79%
Group One Trading
54
Group One Trading
Illinois
– – – –
CFGS
55
Concourse Financial Group Securities
Alabama
– – – –
1 2
3